|
|
english
|
español
|
français
|
Sign Up for an Account
|
Sign In
Country Profiles...
Home
The BCH
The Protocol
Finding Information
Registering Information
Resources
Help
Finding Information
National Contacts
Laws and Regulations
Country's Decisions and other Communications
Submissions
Risk Assessments
Roster of Experts
LMOs, Genes or Organisms
National Reports
Capacity-Building
Organizations
The BCH Virtual Library
Survey on indicators (2014)
Compiled Information
National Contacts
LMO Registry
Organism Registry
Gene Registry
Home
|
Finding Information
|
Record details
|
Risk Assessments
Modified Organism
INNOVAX® ND Vaccine
LMO Information
Decisions on the LMO
Risk Assessments
Tweeter
ID
Description
3
record(s) found
105609
Colombia
Uso del producto INNOVAX ND SB, vacuna aviar para la enfermedad de Marek y la enfermedad de Newcastle serotipos 2 y 3 virus vivo, vector vivo de la enfermedad de Marek.
INNOVAX® ND Vaccine
105613
Colombia
Uso del producto INNOVAX ILT, vacuna aviar para la enfermedad de Marek y la enfermedad de Laringotraqueitis infecciosa aviar
INNOVAX® ND Vaccine
115498
Indonesia
Summary of GMO product environmental risk assessment Nobilis® rHVT-ND (Innovax®-ND)
INNOVAX® ND Vaccine
Contact us
|
Site Map
|
Linkages Policy
|
Privacy Policy
|
Disclaimer
|
© SCBD 2001-2016
Rate this page